All Stories

  1. Lymphatics can metamorphose into blood vessels
  2. Is the prostate cancer marker PSA inducing or inhibiting the growth of blood and lymphatic vessels?
  3. PSA ac­tiv­ates growth factors that con­trib­ut­e to the spread of can­cer
  4. What you need to know about VEGF-C when trying to grow lymphatics for the treatment of lymphedema
  5. Requirements for efficient activation of vascular endothelial growth factor C
  6. Factors regulating the substrate specificity of cytosolic phospholipase A2-alpha in vitro
  7. How to grow lymphatic vessels
  8. Functional Importance of a Proteoglycan Coreceptor in Pathologic LymphangiogenesisNovelty and Significance
  9. The relative importance of the two parts (domains) of the CCBE1 protein
  10. Substrate Efflux Propensity Is the Key Determinant of Ca2+-independent Phospholipase A-β (iPLAβ)-mediated Glycerophospholipid Hydrolysis
  11. The TIE Receptor Family
  12. CCBE1 Enhances Lymphangiogenesis via A Disintegrin and Metalloprotease With Thrombospondin Motifs-3-Mediated Vascular Endothelial Growth Factor-C Activation
  13. Receptor Tyrosine Kinase-Mediated Angiogenesis
  14. Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation
  15. The Basis for the Distinct Biological Activities of Vascular Endothelial Growth Factor Receptor-1 Ligands
  16. A truncation allele in vascular endothelial growth factor c reveals distinct modes of signaling during lymphatic and vascular development
  17. Vascular Endothelial Growth Factor-Angiopoietin Chimera With Improved Properties for Therapeutic Angiogenesis
  18. Critical Role of VEGF-C/VEGFR-3 Signaling in Innate and Adaptive Immune Responses in Experimental Obliterative Bronchiolitis
  19. Structural determinants of vascular endothelial growth factor-D receptor binding and specificity
  20. Effective Suppression of Vascular Network Formation by Combination of Antibodies Blocking VEGFR Ligand Binding and Receptor Dimerization
  21. Suppressive Effects of Vascular Endothelial Growth Factor-B on Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis
  22. Vascular Endothelial Growth Factor-B Acts as a Coronary Growth Factor in Transgenic Rats Without Inducing Angiogenesis, Vascular Leak, or Inflammation
  23. Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development
  24. Structural determinants of growth factor binding and specificity by VEGF receptor 2
  25. Activated Forms of VEGF-C and VEGF-D Provide Improved Vascular Function in Skeletal Muscle
  26. Overexpression of Vascular Endothelial Growth Factor-B in Mouse Heart Alters Cardiac Lipid Metabolism and Induces Myocardial Hypertrophy
  27. The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis
  28. Reevaluation of the Role of VEGF-B Suggests a Restricted Role in the Revascularization of the Ischemic Myocardium
  29. Enhanced Capillary Formation Stimulated by a Chimeric Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor-C Silk Domain Fusion Protein
  30. Distinct Architecture of Lymphatic Vessels Induced by Chimeric Vascular Endothelial Growth Factor-C/Vascular Endothelial Growth Factor Heparin-Binding Domain Fusion Proteins
  31. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors
  32. Vascular Endothelial Growth Factor (VEGF)/VEGF-C Mosaic Molecules Reveal Specificity Determinants and Feature Novel Receptor Binding Patterns
  33. Dual Role of Vascular Endothelial Growth Factor in Experimental Obliterative Bronchiolitis
  34. Vascular Endothelial Cell Growth Factor Receptor 3-Mediated Activation of Lymphatic Endothelium Is Crucial for Tumor Cell Entry and Spread via Lymphatic Vessels
  35. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation
  36. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins
  37. Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function
  38. Genesis and pathogenesis of lymphatic vessels
  39. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
  40. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes
  41. VEGFR-3 alone is sufficient for lymphangiogenesis
  42. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
  43. VEGF-C adenovirus gene transfer reduces intima formation in rabbits
  44. Current biology of VEGF-B and VEGF-C
  45. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity
  46. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells
  47. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
  48. Vascular endothelial growth factors VEGF-B and VEGF-C
  49. Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C
  50. VEGF and VEGF-C: Specific Induction of Angiogenesis and Lymphangiogenesis in the Differentiated Avian Chorioallantoic Membrane
  51. Proteolytic processing regulates receptor specificity and activity of VEGF-C
  52. Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice